Literature DB >> 2766578

Rheumatoid factors in cystic fibrosis: associations with disease manifestations and recurrent bacterial infections.

M Coffey1, J Hassan, C Feighery, M Fitzgerald, B Bresnihan.   

Abstract

Serum IgM and IgA rheumatoid factor (RF) levels were measured by ELISA in 71 adolescent and adult patients with cystic fibrosis (CF) and 69 control subjects. IgM RF values from 15 (21%) CF patients greater than 2 s.d. of control subjects (P less than 0.001). Elevated IgM RF values were significantly associated with worse spirometric measurements of pulmonary function (P less than 0.01) and with more frequent exacerbations of respiratory tract infection (P less than 0.001). A characteristic episodic arthropathy occurred in 27% of IgM RF positive patients, compared with 4% of IgM RF negative patients (P = 0.015). IgA RF values from 26 (37%) CF patients were elevated (P less than 0.001). Pulmonary function was significantly worse in patients with elevated IgA RF values (P less than 0.001). However, IgA RF was not associated with exacerbations of respiratory tract infection or episodic arthropathy. Both IgM and IgA RF values correlated significantly with their corresponding Ig levels, suggesting that RF synthesis was the result of polyclonal B cell activation. It is concluded that serum IgM RF values in CF are associated with worse lung disease and recurring bacterial antigenic stimulation. IgM RF may contribute to the development of arthropathy in some patients. Induction of IgA RF synthesis and its pathogenic potential may differ from IgM RF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766578      PMCID: PMC1541909     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  48 in total

Review 1.  Pathogenesis and management of arthropathy in cystic fibrosis.

Authors:  B M Phillips; T J David
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

2.  ELISA assays for IgM and IgG rheumatoid factors.

Authors:  A Faith; O Pontesilli; A Unger; G S Panayi; P Johns
Journal:  J Immunol Methods       Date:  1982-12-17       Impact factor: 2.303

3.  Immunoglobulin A and polymeric IgA rheumatoid factors in systemic sicca syndrome: partial characterization.

Authors:  K B Elkon; D L Delacroix; A E Gharavi; J P Vaerman; G R Hughes
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

4.  Hypertrophic osteoarthropathy in cystic fibrosis.

Authors:  S Braude; H Kennedy; M Hodson; J Batten
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-17

5.  Molecular forms of IgA rheumatoid factor in serum and synovial fluid of patients with rheumatoid arthritis.

Authors:  R E Schrohenloher; W J Koopman; G S Alarcón
Journal:  Arthritis Rheum       Date:  1986-10

6.  Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study.

Authors:  W B Wheeler; M Williams; W J Matthews; H R Colten
Journal:  J Pediatr       Date:  1984-05       Impact factor: 4.406

7.  Arthritis in cystic fibrosis.

Authors:  D V Schidlow; D P Goldsmith; J Palmer; N N Huang
Journal:  Arch Dis Child       Date:  1984-04       Impact factor: 3.791

Review 8.  The musculoskeletal manifestations of cystic fibrosis.

Authors:  P J Rush; A Shore; C Coblentz; D Wilmot; M Corey; H Levison
Journal:  Semin Arthritis Rheum       Date:  1986-02       Impact factor: 5.532

9.  Episodic arthritis in cystic fibrosis: a case report.

Authors:  G D Summers; M Webley
Journal:  Br J Rheumatol       Date:  1986-11

10.  Cystic fibrosis in adolescents and adults.

Authors:  A R Penketh; A Wise; M B Mearns; M E Hodson; J C Batten
Journal:  Thorax       Date:  1987-07       Impact factor: 9.139

View more
  5 in total

Review 1.  Joint disorders in cystic fibrosis.

Authors:  M A Turner; E Baildam; L Patel; T J David
Journal:  J R Soc Med       Date:  1997       Impact factor: 5.344

2.  Spontaneous in vitro production of rheumatoid factor during infectious exacerbations of cystic fibrosis: correlation with circulating immune complex levels.

Authors:  M T Keogan; M Callaghan; G Yanni; D Mulherin; C Feighery; D L Brown; M X Fitzgerald; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

3.  Prevalence of anti-Fab antibodies in patients with autoimmune and infectious diseases.

Authors:  J Hassan; C Feighery; B Bresnihan; A Whelan
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

4.  IgM, IgG, and IgA rheumatoid factors in pigeon hypersensitivity pneumonitis.

Authors:  Mariana Tellez Araiza; Diana E Aguilar León; Virginia Novelo Retana; Erasmo Martínez-Cordero
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

5.  Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study.

Authors:  Koen M J Janssen; Menke J de Smit; Elisabeth Brouwer; Fenne A C de Kok; Jan Kraan; Josje Altenburg; Marije K Verheul; Leendert A Trouw; Arie Jan van Winkelhoff; Arjan Vissink; Johanna Westra
Journal:  Arthritis Res Ther       Date:  2015-07-09       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.